SCN5A Variant R34C
Summary of observed carriers, functional annotations, and structural context for SCN5A R34C. Data combine curated literature, international cohorts, and gnomAD observations.
Estimated LQT3 penetrance
0%
3/2987 effective observations
Estimated BrS1 penetrance
0%
0/2987 effective observations
Total carriers
2977
0 BrS1 · 3 LQT3 · 2974 unaffected
Variant features alone are equivalent to phenotyping 0 individuals for Brugada syndrome and 0 individuals for LQT3.
In silico predictors
| PROVEAN | PolyPhen-2 | BLAST-PSSM | REVEL | Penetrance Density BrS (%) | Penetrance Density LQT3 (%) |
|---|---|---|---|---|---|
| -3.7 | 0.984 | -2.76 | None | 0 | 2 |
PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).
Reported carrier data
| Source | Year | Carriers | Unaffected | LQT3 | BrS1 | Other | Other Disease |
|---|---|---|---|---|---|---|---|
| 11960580 | 2001 | 2 | 0 | 0 | 0 | ||
| 19322600 | 2009 | 9 | 0 | 0 | 9 | SIDS | |
| 21964171 | 2011 | 1 | 0 | 0 | 1 | SUDS | |
| 23714088 | 2013 | 2 | 2 | 0 | 0 | ||
| 24687331 | 2014 | 1 | 1 | 0 | 0 | ||
| 23571586 | 2013 | 1 | 0 | 0 | 1 | stillbirth, SUDS | |
| 20129283 | 2010 | 44 | 0 | 0 | 0 | ||
| Literature, cohort, and gnomAD | – | 2977 | 2974 | 3 | 0 | – | |
| Variant features alone | – | 15 | 15 | 0 | 0 | – | – |
Totals may differ from individual publications due to duplicate patients removed during curation.
Functional data
Peak and late/persistent current values are relative to wild-type (100% indicates no change). V1/2 activation and inactivation denote the membrane potentials (mV) at which half-maximal current is achieved.
| PubMed ID | Year | Cell Type | Peak Current (% WT) | V1/2 Activation (mV) | V1/2 Inactivation (mV) | Late/Persistent Current (% WT) |
|---|---|---|---|---|---|---|
| 15992732 | 2005 | HEK | 83 | -2 | 0 | |
| 11960580 | 2001 | |||||
| 11997281 | 2002 | |||||
| 15851227 | 2004 | |||||
| 15898185 | 2004 | |||||
| 19322600 | 2009 | |||||
| 21964171 | 2011 | |||||
| 23714088 | 2013 | |||||
| 24687331 | 2014 | |||||
| 23571586 | 2013 | |||||
| 15992733 | 2005 | |||||
| 20129283 | 2010 |
Nearby variants
Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.
| Neighbour residue | Distance (Å) | Observed variants |
|---|---|---|
| 19 | 15 | |
| 20 | 14 | S20F, |
| 21 | 14 | L21V, |
| 22 | 13 | A22V, |
| 23 | 13 | A23S, |
| 24 | 12 | |
| 25 | 11 | E25K, |
| 26 | 11 | |
| 27 | 10 | R27C, R27H, R27L, |
| 28 | 9 | M28L, M28L, M28T, M28I, M28I, M28I, |
| 29 | 8 | A29E, A29V, |
| 30 | 8 | E30G, |
| 31 | 7 | |
| 32 | 5 | |
| 33 | 4 | |
| 34 | 0 | R34C, R34H, |
| 35 | 4 | G35S, |
| 36 | 5 | |
| 37 | 7 | T37A, |
| 38 | 8 | |
| 39 | 8 | L39F, L39F, |
| 40 | 9 | |
| 41 | 10 | |
| 42 | 11 | |
| 43 | 11 | R43X, R43Q, |
| 44 | 12 | |
| 45 | 13 | G45A, |
| 46 | 13 | |
| 47 | 14 | |
| 48 | 14 | E48K, |
| 49 | 15 | E49K |